Apath, LLC is a privately held technology licensing company founded in 1996 by Dr. Charles M. Rice, Nobel Laureate in Medicine 2020. The company specializes in the commercial application of virology and viral genetics to aid pharmaceutical companies in discovering and developing therapeutic products for treating viral infections. Apath holds the fundamental intellectual property required for developing HCV and RSV Therapeutics, Antibodies, Vaccines, and SARS-CoV-2-related therapeutics. The company represents multiple academic institutions and commercial entities and is a premier technology licensing company for research and development tools used to validate therapies for various viruses, including the hepatitis C virus, respiratory syncytial virus, Ebola virus, sindbus virus, West Nile virus, influenza, and SARS-CoV-2. Apath operates in the Biotechnology and Pharmaceutical industries.
Name: Apath, LLC
Slogan: A path to scientific discovery
Description: Apath is a privately held technology licensing company founded by Dr. Charles M. Rice, Nobel Laureate in Medicine 2020, engaged in the commercial application of virology and viral genetics to assist pharmaceutical companies in discovering and developing therapeutic products for the treatment of viral infections.
Founded: 1996
Industries: Biotechnology, Pharmaceutical
As of now, there is no publicly available information about the company's headquarter, last investment, or the last investment's investors.
Taxonomy:
Virology, Viral Genetics, Technology Licensing, Therapeutic Products, Hepatitis C Virus (HCV), Respiratory Syncytial Virus (RSV), Antiviral Research, Molecular Virology, Hemorrhagic Fever Viruses, Antibody Development, Vaccine Development, SARS-CoV-2 Therapeutics, Commercial Application, Drug Development, Academic/Commercial Collaboration
New York, United States
